Differential biomarker expression in head and neck cancer correlates with anatomical localization

Pathology and Oncology Research

Volumn 17, Issue 3, 2011, Pages 721-727

  Tamás, László ^a   Szentkúti, Gabriella ^a   Erős, Mónika ^a   Dános, Kornél ^b   Brauswetter, Diána ^b   Szende, Béla ^b   Zsákovics, Ivett ^b   Krenács, Tibor ^b  

^a Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Anatomical localization related pattern; Biomarker expression; Collagen XVII; EGFR; Head and neck squamous cell carcinoma; Ki67; p53

Indexed keywords

COLLAGEN TYPE 17; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME SPECIFICITY; FEMALE; GLOTTIS; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OROPHARYNX; PATHOLOGICAL ANATOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

EID: 80052729921     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9376-9     Document Type: Article

References (26)

1. G Répássy F-H Cs A Juhász, et al. 1998 Expression of invasion markers CD44v6/v3, NM23 and MMP in laryngeal and hypopharyngeal carcinoma Pathol Oncol Res 4 14 21 9555115 10.1007/BF02904689 (Pubitemid 28257191)
2. J Lukits J Timár A Juhász, et al. 2001 Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization Otolaryngol Head Neck Surg 125 18 22 11458208 10.1067/mhn.2001.116187 1:STN:280:DC%2BD3MvhvVylsA%3D%3D (Pubitemid 33661085)
3. KK Ang J Harris R Wheeler, et al. 2010 Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 24 35 20530316 10.1056/NEJMoa0912217 1:CAS:528:DC%2BC3cXpslyjtr8%3D
4. H Dahlstrand A Näsman M Romanitan, et al. 2008 Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer Anticancer Res 28 1133 1138 18505048 (Pubitemid 351578850)
5. L Vidal ML Gillison 2008 Human papillomavirus in HNSCC: recognition of a distinct disease type Hematol Oncol Clin North Am 22 1125 1142 19010263 10.1016/j.hoc.2008.08.006
6. D Parry S Bates DJ Mann, et al. 1995 Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product EMBO J 14 503 511 7859739 1:CAS:528:DyaK2MXjs1Kgtrw%3D
7. T Andl T Kahn A Pfuhl, et al. 1998 Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control Cancer Res 58 5 13 9426048 1:CAS:528:DyaK1cXitVGntw%3D%3D (Pubitemid 28027707)
8. CH Chung D Raben 2010 p16 expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal Cancer J Clin Oncol 27 4103 4104
9. W Shi H Kato B Perez-Ordonez, et al. 2009 Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma J Clin Oncol 27 6213 6221 19884544 10.1200/JCO.2009.23.1670
10. CS Kong B Narasimhan H Cao, et al. 2009 The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 553 561 19427557 10.1016/j.ijrobp.2009.02.015 1:CAS:528:DC%2BD1MXls1ynt7g%3D
11. E Stelkovics I Korom I Marczinovits, et al. 2008 Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy Appl Immunohistochem Mol Morphol 16 433 441 18633319 10.1097/PAI.0b013e318162f8aa 1:CAS:528:DC%2BD1cXhtFCrtbfN
12. INK4a expression and infiltrative behavior Mod Pathol 17 1464 1474 15257310 10.1038/modpathol.3800220 1:CAS:528:DC%2BD2cXhtFGmsLzL (Pubitemid 39627072)
13. L Ai KK Stephenson W Ling, et al. 2003 The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases Mod Pathol 16 9 944 950 13679459 10.1097/01.MP.0000085760.74313.DD (Pubitemid 37152025)
14. PM Weinberger Z Yu BG Haffty, et al. 2004 Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer Clin Cancer Res 10 17 5684 5691 15355894 10.1158/1078-0432.CCR-04-0448 1:CAS:528:DC%2BD2cXntlOqurw%3D (Pubitemid 39180943)
15. DM Aebersold KT Beer J Laissue, et al. 2000 Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx Int J Radiat Oncol Biol Phys 48 17 25 10924967 10.1016/S0360-3016(00)00573-3 1:STN:280:DC%2BD3czps1altQ%3D%3D (Pubitemid 30488208)
16. C Sittel HE Eckel M Damm, et al. 2000 Ki67 (MIB1), p53, and lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma Laryngoscope 110 1012 1017 10852523 10.1097/00005537-200006000-00024 1:STN:280:DC%2BD3czgvFelsQ%3D%3D (Pubitemid 30368650)
17. KD Somers MA Merrick ME Lopez, et al. 1992 Frequent p53 mutations in head and neck cancer Cancer Res 52 21 5997 6000 1394225 1:CAS:528: DyaK3sXlslamtw%3D%3D
18. CR Bradford S Zhu H Ogawa, et al. 2003 P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines Head Neck 25 8 654 661 12884349 10.1002/hed.10274 (Pubitemid 36909750)
19. A Cabelguenne H Blons I de Waziers, et al. 2000 p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series J Clin Oncol 18 7 1465 1473 10735894 1:CAS:528:DC%2BD3cXivVeisrc%3D (Pubitemid 30205392)
20. S Temam A Flahault S Périé, et al. 2000 p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck J Clin Oncol 18 2 385 394 10637254 1:CAS:528:DC%2BD3cXps1Oqtw%3D%3D (Pubitemid 30056429)
21. KK Ang BA Berkey X Tu, et al. 2002 Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 24 7350 7356 12499279 1:CAS:528:DC%2BD3sXhtV2juw%3D%3D (Pubitemid 36025259)
22. S Kalyankrishna JR Grandis 2006 Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 17 2666 2672 16763281 10.1200/JCO.2005.04.8306 1:CAS:528:DC%2BD28XmslSisbo%3D (Pubitemid 46622088)
23. JR Grandis MF Melhem WE Gooding, et al. 1998 Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 11 824 832 10.1093/jnci/90.11.824 (Pubitemid 28280548)
24. DA Eberhard BE Johnson LC Amler, et al. 2005 Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib J Clin Oncol 23 25 5900 5909 16043828 10.1200/JCO.2005.02.857 1:CAS:528:DC%2BD2MXhtVKgtbzO
25. I Peták R Schwab I Orfi, et al. 2010 Integrating molecular diagnostics into anticancer drug discovery Nat Rev Drug Discov 7 523 535 10.1038/nrd3135
26. G Répássy J Czigner O Ribári, et al. 1988 The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma Arch Otorhinolaryngol 245 151 154 3178563 10.1007/BF00464017